[Expression and Function of miR-144 in β-Thalassemia]

Area of Science:

• Molecular Biology
• Genetics
• Hematology

Context:

• Beta-thalassemia (β-thal) is a group of inherited blood disorders characterized by reduced or absent synthesis of beta-globin chains.
• Understanding the molecular mechanisms underlying β-thal progression is crucial for developing effective diagnostic and therapeutic strategies.
• MicroRNAs (miRNAs) are small non-coding RNAs that play significant roles in gene regulation and have been implicated in various diseases, including hematological disorders.

Purpose:

• To investigate the expression patterns of microRNA-144 (miR-144) during erythroid development.
• To determine the role and expression levels of miR-144 in the context of beta-thalassemia (β-thal).
• To evaluate the potential of miR-144 as a diagnostic biomarker for β-thal.

Summary:

• miR-144 expression was found to progressively increase during the erythroid differentiation of both murine erythroleukemia (MEL) cells and mouse embryonic liver-derived erythroid precursor cells.
• Significantly elevated miR-144 levels were observed in the peripheral blood and embryonic hepatocytes of β-thal mice compared to wild-type (WT) controls.
• Both β-thal patients and mice exhibited higher miR-144 expression in peripheral blood compared to healthy individuals, with severe cases showing markedly increased levels.
• Gene chip analysis revealed reduced expression of miR-144 target genes in nucleated erythroid cells of β-thal mice.

Impact:

• This study elucidates the dynamic expression of miR-144 during erythropoiesis and its dysregulation in β-thalassemia.
• The findings suggest that miR-144 serves as a sensitive indicator of erythroid development and disease severity in β-thal.
• miR-144 holds promise as a valuable auxiliary diagnostic biomarker for clinical assessment of β-thalassemia.